------------------------------------------------------------
[link removed]


** GPP at Pandemic Speed—Participatory Practice in the Age of COVID-19
------------------------------------------------------------
March 25, 2021

Dear Advocates,

AVAC is excited to launch Essential Principles & Practices for GPP Compliance: Engaging stakeholders in biomedical research during the era of COVID-19 ([link removed]) , a new tool to help guide stakeholder engagement in COVID-19 research. Built from the Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials ([link removed]) (GPP), this new document responds to needs expressed by both researchers and advocates as the world watched COVID-19 research progress with unprecedented speed and urgency. Read on for details of a webinar on Thursday, April 1 ([link removed]) , to discuss its applications in the current environment.

In light of—not despite—the urgency of COVID-19 research, it is critical to engage communities and protect the study participants who make this life-saving research possible. As is the case so often in the COVID-19 pandemic, the HIV/AIDS experience provides important lessons.

AVAC and UNAIDS developed GPP ([link removed]) in 2011 as a roadmap for stakeholder engagement throughout the research life cycle. GPP has been subsequently adapted for TB drug trials ([link removed]) , TB vaccine research ([link removed]) , and emerging pathogen research ([link removed]) . This newest iteration of GPP supports researchers and advocates to apply participatory practice with considerations for the exceptional circumstances of COVID-19. It offers practical suggestions to increase the impact of stakeholder engagement while balancing the need for timely research.

To mark the launch of GPP Essentials, AVAC will host a webinar on Thursday, April 1 at 10am ET entitled, Applying GPP Principles and Practices to the Exceptional Circumstances of COVID-19 ([link removed]) . Bartholomew Wilson from the Partnership for Research on Vaccines and Infectious Diseases in Liberia will discuss his recent publication in Nature Medicine ([link removed]) on GPP in pandemic research, followed by a panel discussion with Danielle Campbell (UCLA ([link removed]) ) and Miliswa Magongo (Wits RHI ([link removed]) ) highlighting diverse perspectives on the importance of GPP within COVID-research and beyond.

Register here. ([link removed])

The webinar will be recorded and available afterward on AVAC’s COVID-19 web page ([link removed]) .

If you have any questions ahead of time, please be in touch!

Best,
AVAC


============================================================
Forward This Issue Do you know someone who might be interested in receiving this newsletter?
** Forward > ([link removed])

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe > ([link removed])

Contact Us T: +1 212 796 6423
E: ** [email protected] (mailto:[email protected])
W: ** www.avac.org ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])